Diabetic Retinopathy (DR) Clinical Trials

11 recruiting

Diabetic Retinopathy (DR) Trials at a Glance

11 actively recruiting trials for diabetic retinopathy (dr) are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Char Fasson, Chicago, and Da Nang. Lead sponsors running diabetic retinopathy (dr) studies include Orbis, Data Yakka, Inc., and Da Nang Family General Hospital.

Browse diabetic retinopathy (dr) trials by phase

Treatments under study

About Diabetic Retinopathy (DR) Clinical Trials

Looking for clinical trials for Diabetic Retinopathy (DR)? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetic Retinopathy (DR) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetic Retinopathy (DR) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

Diabetic Retinopathy (DR)Diabete MellitusFundus Photography
VUNO Inc.340 enrolled1 locationNCT07378956
Recruiting
Not Applicable

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Diabetic Retinopathy (DR)Macular Edema (ME)
University of California, San Francisco150 enrolled1 locationNCT07519707
Recruiting
Not Applicable

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Diabetic Retinopathy (DR)Diabetic Macular Edema (DME)
Osijek University Hospital100 enrolled1 locationNCT07520045
Recruiting

Diabetic Retinopathy Prevalence And Risk Factors

Diabetic Retinopathy (DR)
Da Nang Family General Hospital300 enrolled1 locationNCT07468058
Recruiting
Not Applicable

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

Diabetic Retinopathy (DR)
University of Illinois at Chicago60 enrolled1 locationNCT07296952
Recruiting

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

Diabetic Retinopathy (DR)Diabetic Retinopathy Associated With Type 2 Diabetes MellitusDiabetes (DM)+1 more
Sara A Belal70 enrolled1 locationNCT07351786
Recruiting

Assessment of AI Program 'DRISTi' as a Screening Tool

Diabetic Retinopathy (DR)
Artelus AI900 enrolled2 locationsNCT07222293
Recruiting
Not Applicable

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

Diabetes MellitusDiabetic Retinopathy (DR)
Orbis640 enrolled2 locationsNCT06968611
Recruiting
Not Applicable

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side

Diabetes MellitusDiabetic Retinopathy (DR)
Orbis336 enrolled2 locationsNCT06968637
Recruiting

"My Eyes, My Light": Amar Chokh, Amar Alo

MyopiaDiabetic Retinopathy (DR)Presbyopia+6 more
Data Yakka, Inc.20,000 enrolled1 locationNCT07135570
Recruiting

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Diabetic Retinopathy (DR)Diabetic Retinopathy Associated With Type 2 Diabetes MellitusDiabetic Macular Edema (DME)
Hywel Dda Health Board120 enrolled1 locationNCT06914778